Thai biopharmaceuticals firm Siam Bioscience Co. Ltd. is planning to begin commercial business operations for monoclonal antibodies in 2019. As…...
Please subscribe to read the full story.
Japan's leading chemical industry newspaper
Footer
© 2016–2022 The Chemical Daily Co. Ltd., Bonuterra Inc. All Rights Reserved.
